Cormorant Asset Management, LP Cabaletta Bio, Inc. Transaction History

Cormorant Asset Management, LP

$628 Million
Q3 2025

A detailed history of Cormorant Asset Management, LP transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Cormorant Asset Management, LP holds 5,000,000 shares of CABA stock, worth $11.6 Million. This represents 1.86% of its overall portfolio holdings.

Number of Shares

5,000,000

Previous 5,000,000 -0.0%

Holding current value

$11.6 Million

Previous $7.6 Million 53.29%

% of portfolio

1.86%

Previous 0.77%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$1.04 - $2.48 $5.2 Million - $12.4 Million	5,000,000 New	5,000,000 $7.6 Million
Q1 2024 May 15, 2024	BUY	$16.79 - $25.38 $18.5 Million - $27.9 Million	1,100,000 New	1,100,000 $18.8 Million
Q3 2023 Nov 14, 2023	BUY	$11.84 - $18.65 $7.79 Million - $12.3 Million	657,685 Added 29.6%	2,879,424 $43.8 Million
Q2 2023 Aug 14, 2023	BUY	$7.65 - $13.95 $3.06 Million - $5.58 Million	400,000 Added 21.96%	2,221,739 $28.7 Million
Q1 2023 May 15, 2023	SELL	$7.08 - $12.62 $1.06 Million - $1.89 Million	-150,000 Reduced 7.61%	1,821,739 $15.1 Million
Q4 2022 Feb 14, 2023	BUY	$0.64 - $9.3 $523,081 - $7.6 Million	817,315 Added 70.8%	1,971,739 $18.2 Million
Q4 2021 Feb 14, 2022	SELL	$3.36 - $14.64 $1.54 Million - $6.69 Million	-457,199 Reduced 28.37%	1,154,424 $4.38 Million
Q2 2021 Aug 16, 2021	SELL	$7.2 - $11.73 $2.11 Million - $3.43 Million	-292,801 Reduced 15.37%	1,611,623 $13.9 Million
Q4 2020 Feb 16, 2021	SELL	$9.81 - $15.8 $1.6 Million - $2.57 Million	-162,878 Reduced 7.88%	1,904,424 $23.8 Million
Q3 2020 Nov 16, 2020	SELL	$9.71 - $14.41 $374,242 - $555,390	-38,542 Reduced 1.83%	2,067,302 $22.4 Million
Q2 2020 Aug 14, 2020	SELL	$6.39 - $11.28 $12 - $22	-2 Reduced -0.0%	2,105,844 $23.5 Million
Q1 2020 May 15, 2020	SELL	$6.0 - $18.67 $79,716 - $248,049	-13,286 Reduced 0.63%	2,105,846 $15.4 Million
Q4 2019 Feb 14, 2020	BUY	$7.88 - $17.71 $16.7 Million - $37.5 Million	2,119,132 New	2,119,132 $29.6 Million

Others Institutions Holding CABA

# of Institutions

Shares Held

72.8M

Call Options Held

1.1M

Put Options Held

14.9K

View Full List

About Cabaletta Bio, Inc.

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $67M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

More about CABA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Account

Cormorant Asset Management, LP Cabaletta Bio, Inc. Transaction History